Antimicrobial resistance: Paradox, actions and economics

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 6, 2006, Pages 1024-1025

  Wise, Richard ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antibiotic policy; Prescribing practice; Resistance

Indexed keywords

ACTIVATED PROTEIN C; ANTIINFECTIVE AGENT; NEW DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; DRUG COST; DRUG RESEARCH; EDITORIAL; GOOD CLINICAL PRACTICE; GOVERNMENT; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH ECONOMICS; HOSPITAL CARE; HUMAN; MEDICAL AUDIT; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; UNITED KINGDOM; DRUG UTILIZATION; ECONOMICS; NOTE; RESEARCH;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HEALTH POLICY; HUMANS; RESEARCH;

EID: 33749183118     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl138     Document Type: Editorial

References (7)

1. Scottish Executive Health Department. Antimicrobial Resistance Strategy and Scottish Action Plan. SEHD, Edinburgh, UK, 2002. http://www.scotland.gov.uk/library5/health/arsap-00.asp (24 February 2006, date last accessed).
2. Nathwani D. Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals. J Antimicrob Chemother 2006; 57: 1189-96.
3. Projan SJ. Why is big Pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 2003; 6: 427-30.
4. White RJ. Are the rules different for Biotech companies? In: Abstracts of the Forty-third Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2003. Abstract 1126, p. 519. American Society for Microbiology, Washington, DC, USA.
5. Metlay JP, Powers JH, Dudley MN et al. Antimicrobial drug resistance, regulation, and research. Emerg Infect Dis 2006; 12: 183-90.
6. NHS collaboration of the United Kingdom Medicines Information Pharmacists' Group and The National Prescribing Centre. New Drugs in Clinical Development. Drotrecogin alfa (activated). November 2001. http://www.ukmi.nhs.uk/NewMaterial/Secure/Drotrecogin.pdf (24 February 2006, date last accessed).
7. Infectious Diseases Society of America. Bad Bugs, No Drugs. IDSA, Alexandria, VA. USA, July 2004. http://www.idsociety.org/pa/ IDSA_Paper4_final_web.pdf (24 February 2006, date last accessed).